Waheed Nadia bought OCUL
August 12, 2025 · Form 4 insider transaction
Waheed Nadia bought 40,363 shares of Ocular Therapeutix, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,363
Price
$0.00
Total value
N/A
InsiderWaheed Nadia
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 12, 2025
Filing dateAugust 14, 2025
Shares owned after247,168
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On August 12, 2025, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal annual installments, beginning on February 11, 2026.